The weekly litigation news digest is live. Subscribe now

IP Verse

Diagnostic Methods For T Cell Therapy - EP3302507

The patent EP3302507 was granted to Kite Pharma on Feb 22, 2023. The application was filed on May 27, 2016 under application number EP16800846A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3302507

KITE PHARMA
Application Number
EP16800846A
Filing Date
May 27, 2016
Status
Granted And Under Opposition
Jan 20, 2023
Publication Date
Feb 22, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
BOULT WADE TENNANTNov 22, 2023BOULT WADE TENNANTADMISSIBLE

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2002006409
DESCRIPTIONUS2014154228
DESCRIPTIONUS5728388
DESCRIPTIONWO2008081035
INTERNATIONAL-SEARCH-REPORTUS2013195800
INTERNATIONAL-SEARCH-REPORTUS2014377334
INTERNATIONAL-SEARCH-REPORTWO2013169386
INTERNATIONAL-SEARCH-REPORTWO2015069770
OTHERUS2018344767
SEARCHWO2016191756

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents